[go: up one dir, main page]

DK3303579T3 - Assays til at identificere genetiske elementer, der påvirker fænotype - Google Patents

Assays til at identificere genetiske elementer, der påvirker fænotype Download PDF

Info

Publication number
DK3303579T3
DK3303579T3 DK16744892.7T DK16744892T DK3303579T3 DK 3303579 T3 DK3303579 T3 DK 3303579T3 DK 16744892 T DK16744892 T DK 16744892T DK 3303579 T3 DK3303579 T3 DK 3303579T3
Authority
DK
Denmark
Prior art keywords
assays
genetic elements
identify genetic
influence phenotype
phenotype
Prior art date
Application number
DK16744892.7T
Other languages
English (en)
Inventor
Thijn Reinout Brummelkamp
Lucas Tilmann Jae
Markus Brockmann
Vincent Arthur Blomen
Matthijs Raaben
Joppe Daniël Maria Nieuwenhuis
Original Assignee
Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis filed Critical Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis
Application granted granted Critical
Publication of DK3303579T3 publication Critical patent/DK3303579T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1051Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • C12N15/1024In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1079Screening libraries by altering the phenotype or phenotypic trait of the host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK16744892.7T 2015-05-28 2016-05-27 Assays til at identificere genetiske elementer, der påvirker fænotype DK3303579T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2014877 2015-05-28
PCT/NL2016/050381 WO2016190743A1 (en) 2015-05-28 2016-05-27 Assays to identify genetic elements affecting phenotype

Publications (1)

Publication Number Publication Date
DK3303579T3 true DK3303579T3 (da) 2021-05-31

Family

ID=53718102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16744892.7T DK3303579T3 (da) 2015-05-28 2016-05-27 Assays til at identificere genetiske elementer, der påvirker fænotype

Country Status (9)

Country Link
US (2) US10351845B2 (da)
EP (2) EP3892724A1 (da)
JP (1) JP6847930B2 (da)
CN (1) CN107922936B (da)
AU (1) AU2016266427B2 (da)
CA (1) CA2987383C (da)
DK (1) DK3303579T3 (da)
ES (1) ES2878185T3 (da)
WO (1) WO2016190743A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3892724A1 (en) 2015-05-28 2021-10-13 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Assays to identify genetic elements affecting phenotype
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN109355245A (zh) * 2018-12-24 2019-02-19 江南大学 一种基于流式细胞术超高通量分离酿酒酵母单倍体的方法
CN116087069B (zh) * 2023-04-10 2023-08-08 苏州药明康德新药开发有限公司 一种基于流式细胞术检测特定细胞群体组蛋白甲基化和乙酰化修饰水平的方法
WO2025153714A1 (en) 2024-01-19 2025-07-24 Scenic Biotech Bv Pla2g15 inhibitors for use in the treatment of lysosomal storage diseases, hiv, alzheimer's disease or parkinson's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101346724B (zh) * 2005-11-26 2018-05-08 纳特拉公司 清除干扰遗传数据,并使用遗传数据进行预测的方法和体系
EP2396430B1 (en) 2009-02-16 2013-05-01 Epicentre Technologies Corporation Template-independent ligation of single-stranded dna
JP5886195B2 (ja) 2009-07-09 2016-03-16 ホワイトヘッド・インスティチュート・フォア・バイオメディカル・リサーチ 哺乳動物遺伝学のための組成物および方法、ならびにその使用
EA038600B1 (ru) * 2012-04-02 2021-09-21 Берг Ллк Основанные на клетках перекрестные анализы и их применение
EP3892724A1 (en) 2015-05-28 2021-10-13 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Assays to identify genetic elements affecting phenotype

Also Published As

Publication number Publication date
CA2987383C (en) 2023-10-24
CA2987383A1 (en) 2016-12-01
EP3303579A1 (en) 2018-04-11
JP2018525024A (ja) 2018-09-06
AU2016266427A1 (en) 2017-12-21
EP3303579B1 (en) 2021-04-07
ES2878185T3 (es) 2021-11-18
US20180163197A1 (en) 2018-06-14
AU2016266427B2 (en) 2022-01-13
US10351845B2 (en) 2019-07-16
CN107922936A (zh) 2018-04-17
US20190309287A1 (en) 2019-10-10
WO2016190743A1 (en) 2016-12-01
JP6847930B2 (ja) 2021-03-24
CN107922936B (zh) 2021-10-22
EP3892724A1 (en) 2021-10-13

Similar Documents

Publication Publication Date Title
HUE056911T2 (hu) Genetikai konstrukció
MA43259A (fr) Liants ctla4
DK3334824T3 (da) Pd-1-antistoffer
DK3129487T3 (da) Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression
DK3102722T3 (da) Genom fraktionering
DK3113883T3 (da) Cellesorteringssystem der anvender mikrofremstillede komponenter
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3298718T3 (da) Teknikker til signal-forlængelsessignalering
EP3327220A4 (en) BINDING MACHINE
DK3198284T3 (da) Paletbaserede systemer til analytkarakterisering
DK3125898T3 (da) Farmakofor til trail-induktion
MA42692A (fr) Compositions biopharmaceutiques
EP3388526A4 (en) MICRO BACTERIA
DK3262182T3 (da) Modificeret creatinase
EP3322963A4 (en) Diverting checkweigher
EP3327221A4 (en) BINDING MACHINE
EP3399032A4 (en) NOVEL BETA GALACTOSIDASE
DK3296597T3 (da) Krydshovedmotor
EP3341117C0 (en) Reactor
EP3343641A4 (en) PHOTO DETECTOR
DK3206535T3 (da) Ligevægtsledforbindelse
EP3390240A4 (en) LOADING STRUCTURE
EP3336527A4 (en) X-ray fluorescence spectrometer
DK3513192T3 (da) Celledødsbiomarkør
HUE042031T2 (hu) Csökkentett biuret-tartalmú mûtrágya